An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Investigational Site Number : 2760064, Berlin

Investigational Site Number : 2760062, Hamburg

Investigational Site Number : 7240053, Madrid

Investigational Site Number : 7240052, Madrid

Investigational Site Number : 2760061, Bremen

Investigational Site Number : 4840061, Guadalajara

Investigational Site Number : 7240051, Valencia

Investigational Site Number : 2760060, Sankt Augustin

Investigational Site Number : 2030041, Brno

Investigational Site Number : 4840060, Monterrey

Investigational Site Number : 2500040, Paris

Children's Hospital Los Angeles Site Number : 8400416, Los Angeles

Investigational Site Number : 6430001, Moscow

Investigational Site Number : 6430062, Moscow

Investigational Site Number : 6430063, Moscow

Investigational Site Number : 0320060, CABA

Investigational Site Number : 0320004, San Miguel de Tucumán

Investigational Site Number : 1240112, Montreal

Investigational Site Number : 1520016, Concepción

Investigational Site Number : 3800052, Roma

Investigational Site Number : 2460040, Helsinki

Investigational Site Number : 5280020, Utrecht

Investigational Site Number : 6160074, Bydgoszcz

Investigational Site Number : 6160073, Krakow

Investigational Site Number : 6160070, Lublin

Investigational Site Number : 6160071, Lodz

Investigational Site Number : 6160072, Sosnowiec

Investigational Site Number : 7240050, Esplugues de Llobregat

Investigational Site Number : 8260031, London

Investigational Site Number : 8260033, Liverpool